Comparison of a Non Contact Vital Signs Application With Traditional Pulse Oximetry for Heart Rate Measurement
Darwin
1 other identifier
interventional
200
1 country
1
Brief Summary
The investigators want to test the accuracy of the Smartphone application Darwin Edge rVSM in measuring heart rate, as compared to traditional pulsoxymetry. The intervention is to look at the smartphone camera for approximately 30 seconds, and after that to compare the heart rate value with that obtained with a recording by pulsoxymetry.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2024
CompletedFirst Posted
Study publicly available on registry
June 3, 2024
CompletedStudy Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2024
CompletedNovember 22, 2024
November 1, 2024
4 months
May 22, 2024
November 20, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Heart rate
accuracy of heart rate measurement
1 minute
Study Arms (2)
Pulse oxymetry
ACTIVE COMPARATORPulse oxymetry is one of the gold standards for non invasive measurement of heart rate.
Smartphone app
EXPERIMENTALThis is a new smartphone application which can potentially measure heart rate in less than 30 seconds.
Interventions
The participant must look into the smartphone camera with the Darwin app for about 30 seconds.
Eligibility Criteria
You may qualify if:
- Men or women older than 18 years old presenting to the preanesthetic assessment clinic of Valais Hospital
- Subjects that have signed the informed consent form
You may not qualify if:
- subjects with damaged/injured skin at the face
- Subjects unable to remain still for 30 seconds
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hôpital du Valaislead
- University of Lausanne Hospitalscollaborator
Study Sites (1)
Valais Hospital
Sion, Valais, 1950, Switzerland
Study Officials
- STUDY DIRECTOR
Patrick Schoettker, MD
University of Lausanne Hospitals
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 22, 2024
First Posted
June 3, 2024
Study Start
July 1, 2024
Primary Completion
October 31, 2024
Study Completion
October 31, 2024
Last Updated
November 22, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share